State of the art. Neonatal respiratory failure.
Advances in ventilatory management of respiratory distress in the newborn have made dramatic strides during the last decade. Innovative treatments such as PTV, HFV, liquid ventilation, and NO therapy are just beginning to have an impact on the care of neonates in the NICU. These treatment modalities should continue to have an effect on the care of the newborn infant well into the future.
Parker
L A
LA
Department of Nursing, College of Nursing, University of Florida, Gainesville, USA.
D001993:Bronchodilator Agents / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D015931:Intensive Care, Neonatal / Q000379:methods* / Q000639:trends; D017283:Neonatal Nursing / Q000379:methods; D009569:Nitric Oxide / Q000627:therapeutic use*; D012121:Respiration, Artificial / Q000379:methods* / Q000451:nursing / Q000639:trends; D012127:Respiratory Distress Syndrome, Newborn / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*
D001993:Bronchodilator Agents; D009569:Nitric Oxide